SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hoechst (HOE) -- Ignore unavailable to you. Want to Upgrade?

To: Judith Malley M who wrote (5)4/7/1998 12:48:00 PM
From: Judith Malley M  Respond to of 42
 
Am getting closer in my search. I believe HMR is a subsidiary of Hoechst, (HOE).

J.



To: Judith Malley M who wrote (5)4/23/1998 1:13:00 PM
From: Robert L. Ray  Read Replies (1) | Respond to of 42
 
Ya, as far as I can tell Hoechst Marion Roussel is a subsidiary of HOE. The (HMR) heading of this thread is certainly misleading. I did a search and there's no such ticker symbol. At any rate I'm in HOE at 38. Seems like a good value for a drug stock. Course it's not a pure play drug stock. Does anyone know what percentage of HOE's business in in drugs?



To: Judith Malley M who wrote (5)5/22/1998 9:58:00 AM
From: Solid Play  Respond to of 42
 
Hoechst Marion Roussel is basically a subsidiary of Hoechst AG, Germany and to date their has been no public offering of stock specifically in HMR. You basically have to trade HOE or Hoechst AG, and get the whole set of businesses.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News